Insights

Gathering insights about Nucleai…

Similar companies to Nucleai

Nucleai Tech Stack

Nucleai uses 8 technology products and services including LinkedIn Ads, Facebook Pixel, RSS, and more. Explore Nucleai's tech stack below.

LinkedIn Ads
Advertising
Facebook Pixel
Analytics
RSS
Content Management System
Cookiebot
Cookie Compliance
Swiper
Javascript Libraries
HubSpot
Marketing Automation
Yoast SEO
Search Engines
Google Tag Manager
Tag Management

Media & News

Proscia Inc. partnered with Nucleai Inc. on Jul 3rd '24.
Proscia partners with Nucleai to enhance precision medicine with ai-powered pathology.
Jun 26, 2024 | www.mychesco.com
Nucleai Inc. hires Vikas Ahuja as Vice President of Strategic Partnerships.
Nucleai appoints Vikas Ahuja as Vice President of Strategic Partnerships to enable diagnostic deployment and commercialization at scale.
May 16, 2024 | www.businesswire.com
Nucleai Inc. partners with Bgparks.
Nucleai, a spatial AI company with U.S. headquarters at Chicago's Fulton Labs, is partnering with Buffalo Grove clinical research and diagnostics company GoPath Diagnostics to train its AI for use in analysis of clinical trials.
Apr 09, 2024 | www.chicagobusiness.com
Nucleai Inc. integrates with GoPath Global, Inc..
Develop AI-powered Digital Pathology Solutions: Nucleai's AI will be integrated with GoPath's digital pathology platform, creating a powerful solution for clinical trials and diagnostics.
Apr 08, 2024 | hitconsultant.net
Merck Ventures invests into Nucleai Inc. $14M.
- Nucleai, a pioneer in spatial AI biomarkers raises $14M in funding led by M Ventures, the corporate venture arm of Merck KGaA.
Apr 03, 2024 | hitconsultant.net
Section 32 invested into Nucleai Inc. $33M on Jan 1st '22.
Nucleai, an AI-powered spatial biology company, has announced the closure of a $33 million Series B financing round co-led by Section 32 and Sanofi Ventures.
Apr 02, 2024 | www.builtinchicago.org
Nucleai Inc. receives financing of $14M in funding.
Nucleai raises USD 14M funding.
Apr 02, 2024 | www.explorebit.io

Nucleai's Email Address Formats

Nucleai uses at least 2 format(s):

Nucleai Email Formats	Example	Percentage
First@nucleaimd.com	John@nucleaimd.com	74%
Last@nucleaimd.com	Doe@nucleaimd.com	14%
First.Last@nucleaimd.com	John.Doe@nucleaimd.com	7%
FLast@nucleaimd.com	JDoe@nucleaimd.com	4%
LFirst@nucleaimd.com	DJohn@nucleaimd.com	1%
First@nucleai.ai	John@nucleai.ai	100%

Frequently Asked Questions

Where is Nucleai's headquarters located?

Nucleai's main headquarters is located at Chicago, IL US. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is Nucleai's official website and social media links?

Nucleai's official website is nucleai.ai and has social profiles on LinkedIn.

How much revenue does Nucleai generate?

As of November 2024, Nucleai's annual revenue reached $15M.

What is Nucleai's NAICS code?

Nucleai's NAICS code is 5112 - Software Publishers.

How many employees does Nucleai have currently?

As of November 2024, Nucleai has approximately 107 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Chief Operating Officer (coo): D. D. B.Head Of Hr & Recruitment: G. K.Head Of Strategy: D. Z.. Explore Nucleai's employee directory with LeadIQ.

What industry does Nucleai belong to?

Nucleai operates in the Software Development industry.

What technology does Nucleai use?

Nucleai's tech stack includes LinkedIn AdsFacebook PixelRSSCookiebotSwiperHubSpotYoast SEOGoogle Tag Manager.

What is Nucleai's email format?

Nucleai's email format typically follows the pattern of . Find more Nucleai email formats with LeadIQ.

When was Nucleai founded?

Nucleai was founded in 2018.

Nucleai

Software DevelopmentIllinois, United States51-200 Employees

Nucleai Brings AI-powered spatial biology technology to the forefront of precision medicine to improve drug development, clinical treatment decisions, and patient outcomes.

Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.

Nucleai’s Atom: The leading Spatial Biology Platform for Precision Medicine.